Dexcom tests how well the G6 monitor sensors perform with acetaminophen and low oxygen levels, but the FDA found that the company does not have procedures in place to properly monitor and control ...

DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The company response is inadequate. DexCom (NasdaqGS:DXCM) witnessed a 4% ...